[Diagnosis and prognosis of gonadal damage after chemotherapy and irradiation].
Kreuser
E D
ED
Abteilung Innere Medizin mit Schwerpunkt Hämatologie und Onkologie, Klinikum Steglitz, Freien Universität, Berlin.
Klingmüller
D
D
Thiel
E
E
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D003267:Contraception; D015914:Estrogen Replacement Therapy; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D007315:Insemination, Artificial; D008297:Male; D010053:Ovary / Q000187:drug effects* / Q000528:radiation effects; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy; D011247:Pregnancy; D011379:Prognosis; D011446:Prospective Studies; D011878:Radiotherapy / Q000009:adverse effects*; D011879:Radiotherapy Dosage; D013737:Testis / Q000187:drug effects* / Q000528:radiation effects*
D000970:Antineoplastic Agents
Diagnostik und Prognose gonadaler Toxizität nach Chemotherapie und Bestrahlung.